The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Full Text
Right arrow Full Text (PDF, 295K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pani, G.
Right arrow Articles by Paige, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pani, G.
Right arrow Articles by Paige, C. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
© The Rockefeller University Press, 0022-1007/1997/8/581/ $5.00
The Journal of Experimental Medicine, Volume 186, Number 4, August 18, 1997 581-588


Article

The Motheaten Mutation Rescues B Cell Signaling and Development in CD45-deficient Mice

Giovanni Pani*,{ddagger},§, Katherine A. Siminovitch*,{ddagger},§, and Christopher J. Paige*,||

From the * Department of Immunology, {ddagger} Department of Medicine and Molecular and Medical Genetics, University of Toronto, § The Samuel Lunenfeld Research Institute, Mount Sinai Hospital, and || The Wellesley Hospital Research Institute, Wellesley Hospital, Toronto, Ontario, M4Y 1J3, Canada

The cytosolic SHP-1 and transmembrane CD45 protein tyrosine phosphatases (PTP) play critical roles in regulating signal transduction via the B cell antigen receptor (BCR). These PTPs differ, however, in their effects on BCR function. For example, BCR-mediated mitogenesis is essentially ablated in mice lacking CD45 (CD45), but is enhanced in SHP-1–deficient motheaten (me) and viable motheaten (mev) mice. To determine whether these PTPs act independently or coordinately in modulating the physiologic outcome of BCR engagement, we assessed B cell development and signaling in CD45-deficient mev (CD45/SHP-1) mice. Here we report that the CD45/SHP-1 cells undergo appropriate induction of protein kinase activity, mitogen-activated protein kinase activation, and proliferative responses after BCR aggregation. However, BCR-elicited increases in the tyrosine phosphorylation of several SHP-1–associated phosphoproteins, including CD19, were substantially enhanced in CD45/SHP-1, compared to wild-type and CD45 cells. In addition, we observed that the patterns of cell surface expression of µ, {delta}, and CD5, which distinguish the PTP-deficient from normal mice, are largely restored to normal levels in the double mutant animals. These findings indicate a critical role for the balance of SHP-1 and CD45 activities in determining the outcome of BCR stimulation and suggest that these PTPs act in a coordinate fashion to couple antigen receptor engagement to B cell activation and maturation.


Address correspondence to Dr. C. Paige, The Wellesley Hospital Research Institute, Wellesley Hospital, 160 Wellesley St. East, Toronto, Ontario M4Y 1J3, Canada. Phone: 416-926-7751; FAX: 416-926-5109; E-mail: Paige{at}whri.on.ca

1 Abbreviations used in this paper: BCR, B cell antigen receptor; HEL, hen egg lysozyme; HRP, horseradish peroxidase; MAP, mitogen-activated protein; me, motheaten; me v, viable motheaten; PTK, protein tyrosine kinase; PTP, protein tyrosine phosphase.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS